|
Volumn 23, Issue 2 SUPPL. 5, 1996, Pages 11-18
|
Preliminary report on a phase I study of ifosfamide and vinorelbine (Navelbine) in advanced non-small cell lung cancer
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
EDATREXATE;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
GEMCITABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
IRINOTECAN;
MESNA;
MITOMYCIN C;
NAVELBINE;
PACLITAXEL;
PLATINUM;
TOPOTECAN;
VINBLASTINE;
VINCA ALKALOID;
VINDESINE;
ADULT;
ADVANCED CANCER;
AGED;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG TOLERANCE;
FEMALE;
HISTOLOGY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
MALE;
MULTICENTER STUDY;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW;
CARCINOMA, NON-SMALL-CELL LUNG;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
IFOSFAMIDE;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEUTROPENIA;
REMISSION INDUCTION;
SURVIVAL RATE;
VINBLASTINE;
|
EID: 0029875092
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|